The Vanderlaan et al. article published in 2018 is still one of the best summaries of biopharma’s experience with Host Cell Proteins (HCPs).
The Vanderlaan et al. article published in 2018 is still one of the best summaries of biopharma’s experience with Host Cell Proteins (HCPs).